RiceBran Technologies reports revenue uptick in 2017 results after sale of Brazil and contract manufacturing businesses

By Adi Menayang contact

- Last updated on GMT

iStock
iStock
RiceBran Technologies, a company which focuses on rice bran-derived ingredients and formulations, reported revenue of $13.4 million in 2017, a modest 3% increase from $13.0 million in 2016, according to a statement from the company.

President and CEO Robert Smith said in a recent earnings call that the sale of its Healthy Natural contract blending and packaging business​ to Rosewood Private Investments helped pay-off US based debt, while exiting investments in Brazil​later in 2017 helped eliminate any further losses in the operation.

“As we focused our operation and fixed our balance sheet in 2017, we have set the stage to start growing the business,”​ he said.

The company is going to focus on its proprietary ingredient business. Growth in the year was attributed to sales from its Animal Nutrition products, which were up 9%. Meanwhile, food product sales fell 2%.

Focus on companion pet, lifestyle, equine and feed, and protein

“We spent the second half of 2017 strengthening the sales team with key additions to help us in companion pet and protein, augmenting our existing sales strength in areas like lifestyle, bakery, cereal and breading and equine and feed,”​ said Michael Goose, the company’s president of ingredient sales and marketing.

"We are in a strong position to pursue growth opportunities,"​ said Brent Rystrom, COO and CFO. "Our sales team, led by Michael Goose, is making major inroads in identifying and selling to new customers as well as building volumes with existing customers.​ 

“We see this leading to a progressive acceleration in revenue growth beginning in the 2018 second quarter. We plan to hold non-selling expenses flat in 2018, which should drive sharply improving profitability."

Shareholders value up

Year-end cash and cash equivalents totaled $6.2 million in 2017 versus $342,000 at the end of 2016. Due in part to the contract manufacturing sale and divestment from Brazil operations, debt was reduced to $16,000 at the end of 2017 from $9.0 million at the end of 2016.

Shareholders equity totaled $14.7 million at year-end 2017, up from $(632,000) a year earlier.

Related news

Related products

show more

Shaping up in today’s sports nutrition market

Shaping up in today’s sports nutrition market

Lonza - Capsugel | 04-Feb-2020 | Technical / White Paper

What’s driving innovation in the sports nutrition market today? This new white paper from Lonza takes an in-depth look at the most crucial factors, from...

GAME CHANGING ALMOND PROTEIN: READY, SET, GO

GAME CHANGING ALMOND PROTEIN: READY, SET, GO

SABINSA | 03-Feb-2020 | Technical / White Paper

Healthy proteins from the plant world are muscling in on the massive protein powder market, offering a host of ethical, sustainable and vegan options to...

Clinically-Validated Plant-Based Protein & Fiber

Clinically-Validated Plant-Based Protein & Fiber

Bio-gen Extracts Pvt. Ltd. | 01-Nov-2019 | Technical / White Paper

There is an increased interest in health & wellness, fueled by availability and access of information on our fingertips. "We are what we eat"...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars